INVERSAGO-PHARMA
24.1.2023 13:01:37 CET | Business Wire | Press release
Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced that François Ravenelle, Ph.D., Chief Executive Officer, and Glenn Vraniak, MBA, Chief Financial Officer, will host investor meetings during the Private Company Exhibition at the 2023 SVB Securities Global Biopharma Conference being held January 31 through February 2, 2023.
For additional information or to request a meeting with management, please contact conference representatives.
About Inversago Pharma
Inversago Pharma is a privately owned, clinical stage, Canadian biotech company, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting CB1 inverse agonists. Inversago aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as diabetic kidney disease (DKD), including diabetic nephropathy (DN), type 1 and type 2 diabetes (T1D / T2D), non-alcoholic steatohepatitis (NASH), complications of obesity and hypertriglyceridemia (HTG), as well as fibrotic indications like progressive fibrosis-interstitial lung disease (PF-ILD), including idiopathic pulmonary fibrosis (IPF) and other conditions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230124005328/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ on Databricks to Accelerate AI Monetization17.6.2026 09:46:00 CEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse for Databricks, a new offering that brings together LTM’s AI ecosystem, BlueVerse™, with Databricks, the Data and AI company, to accelerate AI-driven data monetization. BlueVerse for Databricks is designed to help enterprises drive tangible business outcomes from data and AI investments by addressing critical challenges in the secure and efficient management of data and compute resources, while optimizing business processes and providing pre-built industry solutions to unlock greater value from AI initiatives. LTM BlueVerse helps companies reimagine core business processes such as procure-to-pay, order-to-cash, hire-to-retire, and marketing operations as AI-optimized workflows. It also enables organizations to accelerate time-to-value through pre-built, industry-specific solutions for Manufacturing, Banking, Financial Services, Insurance, Media & Entertainment, and Retail &
Wolters Kluwer Brings Libra AI Workflows into InView Legal for Belgian Legal Professionals17.6.2026 09:00:00 CEST | Press release
Following the integration of InView content in the Libra by Wolters Kluwer legal AI workspace earlier this year, Libra AI functionalities are now also available in InView Legal Belgium via Libra add-in Wolters Kluwer Legal & Regulatory today announced the integration of Libra by Wolters Kluwer AI workflows in InView Legal (formerly known as Jura) in Belgium. This integration brings generative AI features directly into the research workflow of legal professionals and allows a seamless experience without switching between tools. The integration follows the launch of the Libra legal AI workspace in Belgium in February, combining AI with authoritative legal content from InView Legal and supporting lawyers across their full workflow, from research to analysis and document drafting. With the newly launched Libra add-in for InView Legal customers can use Libra’s AI functionalities for drafting, review and analysis in one unified environment, handling their work end-to-end. The solution reflec
Zoya Technologies Launches Clinical AI Terminal Engineered to Operate Without Internet Connectivity17.6.2026 09:00:00 CEST | Press release
ZoyeMed 3.0 Resilience Edition runs the complete Longitudinal Multimodal Model on-device, supporting a full medical episode - triage, examination, 120+ point-of-care tests, and prescription support - in fully disconnected environments Almost every digital health system assumes the internet will be there. Zoya Technologies today launched the ZoyeMed 3.0 Resilience Edition, a clinical AI terminal engineered to deliver a complete medical episode without an internet connection at any stage. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260617381037/en/ The ZoyeMed 3.0 Resilience Edition - a fully standalone clinical AI terminal engineered to operate without internet connectivity, integrating point-of-care diagnostics, examination tools, and on-device AI in a single 5-square-metre footprint (Photo: AETOSWire) Continuity of care is the first casualty of infrastructure disruption. Disasters, grid instability, and remote deployment
Owl Labs Launches Owl 360 Services, Bringing Enterprise Grade Intelligence to Hybrid Meetings17.6.2026 09:00:00 CEST | Press release
The company's first tiered subscription service delivers differentiated analytics, providing deeper visibility and control across growing device fleets for IT teams globally Owl Labs, the leader in 360-degree AI-powered video conferencing and hybrid collaboration technology, today announced Owl 360 Services, its first subscription service built to meet the needs of IT administrators. As organisations look to support hybrid work with deeper video enablement across more spaces, Owl 360 Services delivers three subscription tiers, offering dedicated support, centralised device management, proactive insights, and warranty coverage scaled to the size and complexity of the deployment. From launch, every Owl Labs device worldwide, whether newly purchased or already owned, is enrolled in the Core tier at no additional cost, giving all customers built-in analytics from the start. The Enhanced tier, available for direct purchase globally from this summer, adds advanced analytics, dashboards, meet
Cognite Launches Novel Integrated Supply Chain Offering to Deliver Unprecedented Business Value with AI17.6.2026 08:00:00 CEST | Press release
AI agents, apps, and data models built on the Cognite AI and Data Platform help operations and supply chain teams increase resiliency, reduce costly decision latency, and protect margins Cognite, a global leader in Industrial AI, today announced the launch of its Integrated Supply Chain offering. This new solution area extends the Cognite AI and Data Platform beyond the plant, equipping industrial teams with real-time visibility, insights, and cross-functional context to finally bridge the long-standing data gap between production and supply chain operations. Unifying these siloed teams empowers organizations to respond faster and smarter to internal or external disruptions, execute adaptive pivots, and better protect margins. The divide between production and supply chain operations has increased over time, as competing KPIs, organizational initiatives, and specialized software further fragment decision-making processes. As a result, any operational disruption can force costly, reacti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom